Type your search query and hit enter:
hypothalamic
Health
Rhythm Pharmaceuticals to Announce Topline Results from Pivotal Phase 3 TRANSCEND Trial Evaluating Setmelanotide in Patients withAcquired Hypothalamic Obesity
Company to host conference call on April 7 at 8 a.m. ET April 06, 2025 12:00 ET | Source: Rhythm…
4 weeks ago